Correction to: YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.
Saved in:
| Title: | Correction to: YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma. |
|---|---|
| Authors: | Hou J; Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China. houjj@sysucc.org.cn.; Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210093, China. houjj@sysucc.org.cn.; Department of Hepatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China. houjj@sysucc.org.cn.; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China. houjj@sysucc.org.cn., Zhang H; Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.; Department of Surgery, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518053, China., Liu J; Department of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, University of Chicago, Chicago, IL, 60637, USA., Zhao Z; Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China., Wang J; Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China., Lu Z; Department of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, University of Chicago, Chicago, IL, 60637, USA., Hu B; School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China., Zhou J; School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China., Zhao Z; Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China., Feng M; Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China., Zhang H; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.; Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, 4006, Australia., Shen B; Key Laboratory of Reproductive Medicine, Department of Histology and Embryology, Nanjing Medical University, Nanjing, 211166, China., Huang X; School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China., Sun B; Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210093, China., Smyth MJ; Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, 4006, Australia., He C; Department of Chemistry, Department of Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, University of Chicago, Chicago, IL, 60637, USA. chuanhe@uchicago.edu.; Howard Hughes Medical Institute, University of Chicago, Chicago, IL, 60637, USA. chuanhe@uchicago.edu., Xia Q; Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China. xiaqiang@shsmu.edu.cn. |
| Source: | Molecular cancer [Mol Cancer] 2020 Sep 04; Vol. 19 (1), pp. 137. Date of Electronic Publication: 2020 Sep 04. |
| Publication Type: | Journal Article; Published Erratum |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1476-4598 |
|---|---|
| DOI: | 10.1186/s12943-020-01257-8 |
